Greenleaf Trust Decreases Stake in Intuitive Surgical, Inc. $ISRG

Greenleaf Trust decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 43.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,494 shares of the medical equipment provider’s stock after selling 8,798 shares during the quarter. Greenleaf Trust’s holdings in Intuitive Surgical were worth $5,140,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the business. D.A. Davidson & CO. grew its stake in Intuitive Surgical by 11.2% during the 3rd quarter. D.A. Davidson & CO. now owns 15,419 shares of the medical equipment provider’s stock valued at $6,896,000 after acquiring an additional 1,556 shares in the last quarter. CWA Asset Management Group LLC lifted its stake in Intuitive Surgical by 16.0% in the 3rd quarter. CWA Asset Management Group LLC now owns 5,189 shares of the medical equipment provider’s stock worth $2,321,000 after purchasing an additional 717 shares in the last quarter. Blue Sky Capital Consultants Group Inc. boosted its holdings in shares of Intuitive Surgical by 13.4% during the 3rd quarter. Blue Sky Capital Consultants Group Inc. now owns 8,748 shares of the medical equipment provider’s stock worth $3,912,000 after purchasing an additional 1,035 shares during the last quarter. Crown Wealth Group LLC grew its position in shares of Intuitive Surgical by 14.4% in the third quarter. Crown Wealth Group LLC now owns 486 shares of the medical equipment provider’s stock valued at $217,000 after purchasing an additional 61 shares in the last quarter. Finally, Stanley Laman Group Ltd. grew its position in shares of Intuitive Surgical by 2,091.5% in the third quarter. Stanley Laman Group Ltd. now owns 13,456 shares of the medical equipment provider’s stock valued at $6,018,000 after purchasing an additional 12,842 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CEO David J. Rosa sold 24,500 shares of Intuitive Surgical stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. This trade represents a 9.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 7,562 shares of the business’s stock in a transaction that occurred on Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at $193,595.79. This trade represents a 95.54% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 114,007 shares of company stock valued at $63,533,844 over the last quarter. 0.70% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Truist Financial raised their target price on Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research note on Thursday, December 18th. UBS Group set a $600.00 price target on shares of Intuitive Surgical and gave the company a “neutral” rating in a research report on Thursday, October 23rd. Piper Sandler upped their price objective on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Finally, Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $612.75.

Intuitive Surgical Stock Up 0.8%

Shares of Intuitive Surgical stock opened at $566.38 on Tuesday. The firm has a market cap of $203.03 billion, a PE ratio of 74.92, a price-to-earnings-growth ratio of 4.57 and a beta of 1.67. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The business’s fifty day simple moving average is $561.77 and its 200-day simple moving average is $509.36.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s quarterly revenue was up 22.9% on a year-over-year basis. During the same period last year, the company earned $1.84 EPS. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.